Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...
Valerion VisionMaster is a new name in projectors, but with backing from AWOL Vision, it’s already turning heads. The ...